Delivery Order SPE2DR25D3501-SPE2DR26FL9TP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,269.27 for 30 mg Isotretinoin capsules (30-count supply) with an ultimate completion date of November 17, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) valued at $8,013.86. The contract was executed on October 30, 2025, with an ultimate completion date of October 31, 2025, and employs firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a $11,778.39 delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,874.48 delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.20 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,074.58 on November 5, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with a ceiling value of $6,658.02 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by September 16, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $2,464.20. This is a firm fixed-price, non-set-aside delivery order awarded on October 22, 2025, with an ultimate completion date of October 23, 2025. The order is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9TPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count supply) with a ceiling value of $8,087.28. This firm fixed-price delivery order was competitively awarded without a set-aside designation and has an ultimate completion date of December 3, 2025. The contract was executed on December 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 million prime vendor agreement running through December 2026 that supports pharmaceutical supply needs across military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies for defense and military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's track record of competitive federal awards demonstrates its capability to meet rigorous federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 12/1/25 |